Renalytix plc (RNLXY)
Sector: Services-Medical Laboratories
OTC:RNLXY
OTC:RNLXY
+2.70%$3.80
Mkt Cap-
EV-
Float-
O/S-
Inst Own-
Net Cash/Sh-
Dilution
MCap-Float-O/S-
Dilution
Pipeline4 lead-sponsored trials·4 active0 completed
Trials need funding. See this company's dilution risk and cash position.
Clinical Trials
Status
- ObservationalActive, not recruiting
Decision Impact Trial of KidneyIntelX
KidneyIntelX
Diabetic Kidney Disease
NCT04791358Enrollment1,500StartNov 2021Primary CompletionNov 2026est.CompletionDec 2026est. - ObservationalRecruiting
Real World Evidence Clinical Utility Study of KidneyIntelX
KidneyIntelX
Chronic Kidney Diseases, Diabetic Kidney Disease
NCT04802395Enrollment10,000StartMar 2021Primary CompletionDec 2026est.CompletionDec 2026est. - ObservationalActive, not recruiting
Prospective Decision Impact Trial of KidneyIntelX
KidneyIntelX
Diabetic Kidney Disease, Chronic Kidney Disease Stage 1 +2
NCT04960514Enrollment2,000StartNov 2021Primary CompletionDec 2023CompletionDec 2026est. - ObservationalActive, not recruiting
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
KidneyIntelX
Diabetic Kidney Disease, Chronic Kidney Diseases +3
NCT05198284Enrollment2,000StartNov 2021Primary CompletionDec 2023CompletionNov 2026est.
| Drug / Therapy | Link | ||
|---|---|---|---|
| Observational | Active, not recruiting | KidneyIntelX | NCT04791358 |
| Observational | Recruiting | KidneyIntelX | NCT04802395 |
| Observational | Active, not recruiting | KidneyIntelX | NCT04960514 |
| Observational | Active, not recruiting | KidneyIntelX | NCT05198284 |